Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.47 |
| ▸ | ARG2 | P78540 | 1/20 | 0.47 |
| ▸ | NOS2 | P35228 | 3/20 | 0.46 |
| ▸ | NOS1 | P29475 | 2/20 | 0.46 |
| ▸ | NOS3 | P29474 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 5/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | GFPT1 | Q06210 | 1/20 | 0.39 |
| ▸ | BHMT | Q93088 | 1/20 | 0.38 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160075 | 0.88 | KIF11 (0.42) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL12438522 | 0.88 | KIF11 (0.42) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL1815745 | 0.88 | KIF11 (0.42) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL1815741 | 0.88 | KIF11 (0.42) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL12438514 | 0.88 | KIF11 (0.42) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL12438513 | 0.88 | KIF11 (0.42) | ARG1ARG2NOS2NOS1NOS3 | |
| Cystine SCHEMBL25390642 | 0.86 | KIF11 (0.41) | ARG1ARG2NOS2NOS1NOS3 | |
| Hydrochloric Acid SCHEMBL22290069 | 0.86 | KIF11 (0.41) | ARG1ARG2NOS2NOS1NOS3 | |
| Hydrochloric Acid SCHEMBL21611699 | 0.86 | KIF11 (0.41) | ARG1ARG2NOS2NOS1NOS3 | |
| Hydrochloric Acid SCHEMBL21611698 | 0.86 | KIF11 (0.41) | ARG1ARG2NOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107531803-B | Cyclic galanin analogs and uses thereof | 兰硫代佩普有限公司 | 2021-11-12 | — | — | CN | claimed |
| CN-106170492-B | Cyclic Apelin analogs | 兰硫代佩普有限公司 | 2020-08-21 | — | — | CN | claimed |
| CN-106188253-B | Antibacterial peptide Lexapeptide and preparation method and application thereof | 上海交通大学 | 2020-08-18 | — | — | CN | claimed |
| EP-3268383-A1 | CYCLIC GALANIN-ANALOGS AND USES THEREOF | LanthioPep B.V. (NL) | 2018-01-17 | — | — | EP | claimed |
| CN-107531803-A | Cyclic galanin analogs and uses thereof | 兰硫代佩普有限公司 | 2018-01-02 | — | — | CN | claimed |
| US-20170107257-A1 | CYCLIC APELIN ANALOGS | LANTHIOPEP B.V. (NL) | 2017-04-20 | — | — | US | claimed |
| EP-3122764-A1 | CYCLIC APELIN ANALOGS | LanthioPep B.V. (NL) | 2017-02-01 | — | — | EP | claimed |
| CN-106170492-A | Cyclic Apelin analogs | 兰硫代佩普有限公司 | 2016-11-30 | — | — | CN | claimed |
| WO-2016146513-A1 | CYCLIC GALANIN-ANALOGS AND USES THEREOF | LANTHIOPEP B.V. (NL) | 2016-09-22 | — | — | WO | claimed |
| WO-2015147641-A1 | CYCLIC APELIN ANALOGS | LANTHIOPEP B.V. (NL) | 2015-10-01 | — | — | WO | claimed |
| WO-2025032101-A1 | NEW COMPOSITION FOR ANTI-AGE TREATMENT OF SKIN | L'ORÉAL (FR) | 2025-02-13 | — | — | WO | disclosed |
| CN-118561963-A | Nicotine acetylcholine receptor peptide antagonist conotoxin compositions and related methods | 格罗制药公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118420728-A | Lanothalapeptide and preparation method and application thereof | 河北省科学院生物研究所 | 2024-08-02 | — | — | CN | disclosed |
| EP-4392048-A1 | PROBIOTIC BACTERIA COMPOSITION FOR INHIBITING FUNGAL PROLIFERATION | Lactobio A/S (DK) | 2024-07-03 | — | — | EP | disclosed |
| CN-118139633-A | Probiotic composition for inhibiting fungal proliferation | 莱托生物股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| EP-0342658-B1 | Biosynthetic process for the preparation of chemical compounds | THOMAE GMBH DR K (DE) | 1994-05-11 | — | — | EP | disclosed |
| EP-0543195-A2 | Biosynthetic process for the preparation of proteins | Dr. Karl Thomae GmbH (DE) | 1993-05-26 | — | — | EP | disclosed |
| EP-0342658-A1 | Biosynthetic process for the preparation of chemical compounds | Dr. Karl Thomae GmbH (DE) | 1989-11-23 | — | — | EP | disclosed |
| EP-0083612-A1 | NEW DERIVATIVES OF DIPEPTIDES, METHOD FOR THE PREPARATION THEREOF AND UTILIZATION THEREOF AS DRUGS | FLORK, Michel (FR) | 1983-07-20 | — | — | EP | disclosed |
| WO-1983000146-A1 | NEW DERIVATIVES OF DIPEPTIDES, METHOD FOR THE PREPARATION THEREOF AND UTILIZATION THEREOF AS DRUGS | FLORK, MICHEL | 1983-01-20 | — | — | WO | disclosed |